COMBINED TREATMENT OF TARDIVE-DYSKINESIA WITH CLONIDINE AND NEUROLEPTICS - A FOLLOW-UP-STUDY OF 3 CASES FOR 3 YEARS

被引:19
作者
NISHIKAWA, T [1 ]
TANAKA, M [1 ]
KOGA, I [1 ]
UCHIDA, Y [1 ]
机构
[1] SEIWAKAI NISHIKAWA HOSP,HAMADA 697,JAPAN
关键词
D O I
10.1007/BF00432124
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
引用
收藏
页码:374 / 375
页数:2
相关论文
共 8 条
[1]   DIFFERENT ALPHA-ADRENORECEPTORS IN CENTRAL NERVOUS-SYSTEM MEDIATING BIOCHEMICAL AND FUNCTIONAL EFFECTS OF CLONIDINE AND RECEPTOR BLOCKING-AGENTS [J].
ANDEN, NE ;
GRABOWSKA, M ;
STROMBOM, U .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1976, 292 (01) :43-52
[2]   TOURETTES DISORDER AND THE USE OF CLONIDINE [J].
FERRE, RC .
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1982, 21 (03) :294-297
[3]   CLONIDINE TREATMENT OF SCHIZOPHRENIA - DOUBLE-BLIND COMPARISON TO PLACEBO AND NEUROLEPTIC DRUGS [J].
FREEDMAN, R ;
KIRCH, D ;
BELL, J ;
ADLER, LE ;
PECEVICH, M ;
PACHTMAN, E ;
DENVER, P .
ACTA PSYCHIATRICA SCANDINAVICA, 1982, 65 (01) :35-45
[4]  
GOLD MS, 1978, LANCET, V2, P599
[5]  
JESTE DV, 1982, J CLIN PSYCHOPHARM, V2, P318
[6]  
JIMERSON DC, 1980, BIOL PSYCHIAT, V15, P45
[7]  
NISHIKAWA T, 1980, Kurume Medical Journal, V27, P209
[8]  
NISHIKAWA T, 1983, EUR J PHARM